8-K - NextCure, Inc. (0001661059) (Filer)
NextCure, Inc.（CIK 0001661059）于2026年10月30日向SEC提交8-K，报告期为2026年10月26日，文件共12份，涉及Item 5.02：董事或某些高管的离任、董事选举、某些高管的任命及薪酬安排。文件未在素材中披露具体人员、离任原因、任命安排或薪酬条款。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-30
Accepted
2026-10-30 08:00:18
Documents
12
Period of Report
2026-10-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Mailing Address PO BOX 1052 FREDERICK MD 21702-0052
Business Address 2850 QUARRY LAKE DRIVE SUITE 280 BALTIMORE MD 21209 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)
EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 261504468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov